Retraction Statement: Paper by Ting Guo, Wenyu Li, and Sijian Wen Entitled "Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study" [Skin Appendage Disord, 2026; DOI: 10.1159/000553570].

Author unknown

Open source

DOI
10.1159/sad/aesag009
Published
2026 Sep 8
Container
Skin appendage disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/sad/aesag009,
  title = {Retraction Statement: Paper by Ting Guo, Wenyu Li, and Sijian Wen Entitled "Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study" [Skin Appendage Disord, 2026; DOI: 10.1159/000553570].},
  year = {2026},
  journal = {Skin appendage disorders},
  doi = {10.1159/sad/aesag009},
  url = {https://doi.org/10.1159/sad/aesag009}
}

RIS

TY  - JOUR
TI  - Retraction Statement: Paper by Ting Guo, Wenyu Li, and Sijian Wen Entitled "Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study" [Skin Appendage Disord, 2026; DOI: 10.1159/000553570].
PY  - 2026
JO  - Skin appendage disorders
DO  - 10.1159/sad/aesag009
UR  - https://doi.org/10.1159/sad/aesag009
ER  - 

APA

Retraction Statement: Paper by Ting Guo, Wenyu Li, and Sijian Wen Entitled "Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study" [Skin Appendage Disord, 2026; DOI: 10.1159/000553570].. (2026). Skin appendage disorders. https://doi.org/10.1159/sad/aesag009

Source records